The FTO check from MyBody-X targets common variants (e.g., rs9939609) linked to a modest increase in BMI. Each risk allele raises BMI by roughly 0.3 kg/m² on average – a small effect compared to lifestyle factors like diet, exercise, and sleep. MyBody-X markets this as a 'gene turbo' for weight management, but the evidence is moderate: associations come from GWAS, mostly in European cohorts, with limited transferability to other ancestries. Polygenic risk scores for obesity explain only a fraction of weight variation. Therefore, an FTO result alone should not trigger drastic dietary changes. It is best used as one piece of a broader health picture, alongside validated lifestyle interventions. Caveat: DTC genetic tests are not clinically validated for diagnosis or treatment decisions. For significant weight concerns, consult a healthcare professional.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-83b819ab2cce8a0abf745d19